Paper Details

  1. Home
  2. Paper Details

Response to triple treatment with omeprazole, amoxicillin, and clarithromycin for Helicobacter pylori infections in continuous ambulatory peritoneal dialysis patients.

Author: ErtugrulC, Fevzi ErsoyF, IsitanF, SarikayaM, SuleymanlarG, SuleymanlarI, Tugrul SezerM, TuncerM, YakupogluG

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Overview

Triple therapy with omeprazole, amoxicillin, and clarithromycin was found to be effective in eradicating Helicobacter pylori infection in patients on continuous ambulatory peritoneal dialysis (CAPD), with an eradication rate similar to the normal population.
Paper Details　
Original Abstract of the Article :
In this study, the response to triple treatment with omeprazole, amoxicillin, and clarithromycin was investigated in continuous ambulatory peritoneal dialysis (CAPD) patients with Helicobacter pylori (Hp) infections. The study enrolled 20 CAPD patients (11 male, 9 female) who had dyspeptic complaint...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://pubmed.ncbi.nlm.nih.gov/10682076

データ提供：米国国立医学図書館（NLM）

Triple Treatment for Helicobacter pylori Infections in Continuous Ambulatory Peritoneal Dialysis Patients

Continuous ambulatory peritoneal dialysis (CAPD) is a lifeline for patients with kidney failure. This study explores the efficacy of a triple treatment regimen, combining omeprazole, amoxicillin, and clarithromycin, for Helicobacter pylori (Hp) infections in CAPD patients. The researchers, like skilled desert healers, sought to find a safe and effective way to combat this common bacterial infection in a vulnerable population.

The study reveals that the triple treatment regimen is as effective in eradicating Hp infection in CAPD patients as it is in the general population. This finding provides clinicians with valuable information for managing Hp infections in CAPD patients, ensuring they receive appropriate and effective treatment.

Protecting Vulnerable Populations: A Journey Towards Safe and Effective Treatment

This study demonstrates the importance of providing effective treatment for common infections in vulnerable populations. The finding that the triple treatment regimen is as effective in CAPD patients as in the general population provides reassurance that these patients can receive appropriate care for Hp infections, ensuring their health and well-being.

Dr. Camel's Conclusion

This study highlights the importance of ensuring that vulnerable populations receive effective treatment for common infections. The findings provide clinicians with valuable information for managing Hp infections in CAPD patients, allowing them to offer safe and effective care, ensuring a healthier journey for their patients.

Date :
  1. Date Completed 2000-04-11
  2. Date Revised 2013-11-21
Further Info :

Pubmed ID

10682076

DOI: Digital Object Identifier

10682076

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.